Dr. Uriel Sandkovsky, MD, MS
What this data tells you about Dr. Sandkovsky
Dr. Uriel Sandkovsky is an internal medicine in Dallas, TX, with 16 years in practice. Based on federal Medicare data, Dr. Sandkovsky performed 17,158 Medicare services across 1,532 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sandkovsky received a total of $290,387 from 42 pharmaceutical and/or device companies across 857 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sandkovsky is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 13,500 | $18 | $50 |
| Hospital follow-up visit, high complexity | 1,103 | $93 | $289 |
| Hospital follow-up visit, moderate complexity | 776 | $62 | $202 |
| Office visit, established patient (30-39 min) | 420 | $79 | $279 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 339 | $50 | $394 |
| Drug injection, under skin or into muscle | 289 | $10 | $59 |
| Initial hospital admission, high complexity | 268 | $137 | $546 |
| Injection, zoledronic acid, 1 mg | 190 | $6 | $41 |
| Injection, ertapenem sodium, 500 mg | 75 | $10 | $79 |
| Office visit, established patient (20-29 min) | 67 | $48 | $185 |
| New patient office visit (45-59 min) | 40 | $113 | $425 |
| Office visit, established patient, complex (40-54 min) | 25 | $130 | $377 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 23 | $83 | $303 |
| Initial hospital admission, moderate complexity | 22 | $103 | $372 |
| Insertion of tube for infusion with imaging guidance and review by radiologist, patient 5 years or older | 21 | $283 | $1,225 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for internal medicine in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sandkovsky is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (speaking/promotional, top 1%), with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sandkovsky experienced with denosumab injection (prolia/xgeva)?
Does Dr. Sandkovsky receive payments from pharmaceutical companies?
How do Dr. Sandkovsky's costs compare to other internal medicines in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology